LOGIN
SIGN UP

PATHWAYS

EvidenceCare offers healthcare providers complete access to content curated by some of the industry’s foremost experts. We continue to develop content to meet the needs of our customers.
Click on any Pathway, Guide or Author to learn more.

CURRENT GUIDES & AUTHORS

 

Antibiotic Guide

Our Antibiotic Guide is a comprehensive resource for providers to access antimicrobial treatment regimens on nearly every infectious condition. Whether your patient has sepsis, a Hospital-Acquired Pneumonia (HAP), or is a child with meningitis, we have you covered. Furthermore, we allow you to customize the treatment regimen based on variables (such as weight and drug allergies) that are specific to your patient.

CME Credits: 0.00

Frank LoVecchio, DO, MPH, FACP, ABMT
Maricopa Medical Center
Tarascon Pharmacopoeia

Tarascon is committed to providing health care providers the best available portable medical references. Our acclaimed series of pocket guides succinctly distills and organizes hard-to-remember yet vitally important clinical information. Written by experts in their fields, readers repeatedly tell us that they are “must-have” books.

Founded by Dr. Steven Green in 1987, Tarascon Publishing has grown from a single drug book to a robust series that includes several versions of the Pharmacopoeia as well as clinical pocketbooks in over 15 specialty areas. Our broad customer base includes students, physicians, nurses, other healthcare professionals, and pharmaceutical companies. Tarascon products offer unmatched accuracy, timeliness, quality, and expertise and they have received the highest praise from medical journals, residents, and other health care providers. Jones & Bartlett Learning acquired Tarascon Publishing in 2008 and has been expanding on their offering ever since.

“Over the last 21 years, Tarascon has built a worldwide reputation for our acclaimed series of ‘must-have’ clinical books written by leading medical experts. I’m pleased that with the ongoing commitment to providing health care providers the best available portable medical references, that the Tarascon brand is in good hands and will continue to flourish with Jones & Bartlett Learning,” Steve Green, MD, President and Founder of Tarascon Publishing. Click to learn more about the Tarascon Publishing Team or visit our Product Catalog to view our print, online and mobile offerings.

CME Credits: 0.00

US Preventative Services Task Force

The U.S. Preventive Services Task Force is an independent panel of experts in primary care and prevention who systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services. These reviews are published as U.S. Preventive Services Task Force recommendations on the Task ForceWeb site and/or in a peer-reviewed journal.

CME Credits: 0.00

CURRENT PATHWAYS & AUTHORS

 

Acute Coronary Syndrome (ACS)

Cardiovascular disease is the leading cause of death worldwide. The EvidenceCare Acute Coronary Syndrome (ACS) pathway is based off of the 2013 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) STEMI guidelines, 2014 American College of Cardiology/American Heart Association (ACC/AHA) NSTEMI guidelines and includes the 2015 American Heart Association (AHA) Acute Coronary Syndromes update.

All phases of ACS care are addressed, with focus on appropriate intervention strategies for NSTEMI and STEMI care, including care of patients after resuscitated cardiac arrest with suspected ACS. Included are the 2015 updates on STEMI care that reflect guideline changes based on the interval of time of symptom onset to intervention versus previous recommendations based on interval from first medical contact to intervention.

CME Credits: 8.00

Adult Cardiac Life Support (ACLS)

The EvidenceCare Advanced Cardiac Life Support pathway is based off the 2015 American Heart Association (AHA) guidelines. This offers providers a structured approach to managing fatal arrhythmias and adult resuscitation. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests.
CME Credits: 2.00

Asthma

The EvidenceCare Asthma pathway allows providers to utilize a structured approach to the management of pediatric and adult patients with Asthma. Topics that are covered include: new diagnosis, persistent/chronic symptom management using a Step approach, acute exacerbations, and impending respiratory arrest. The Pediatric Asthma Score (PAS) and the Pediatric Respiratory Asthma Measurement (PRAM) are embedded as decision rules to help the provider risk stratify their patient.

Guidelines recommendations are included from the Managing Asthma Exacerbations in the Emergency Department Summary of the National Asthma Education and Prevention Program Expert Panel (ATS 2009), British Guidelines on the Management of Asthma (2014), and multiple Cochrane Database Systematic Reviews.

CME Credits: 1.00

Concussion

Concussions present many challenges to providers including initial assessment of severity of injury, management of acute and prolonged concussive symptoms and evaluation of patients for readiness to return to activities.

The EvidendeCare Concussion pathway provides recommendations for the immediate evaluation of mild traumatic brain injury and includes decision tools to assess the need for neuro-imaging. We also address the rapidly evolving understanding of post-concussion syndrome and include guidelines for return to work, school and sports post-concussion.

Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians, Centers for Disease Control (CDC), Veterans Health Administration and Department of Defense (VA/DoD), Ontario Neurotrauma Foundation (ONF) and Consensus Statement from the 4th International Conference on Concussion in Sport.

CME Credits: 3.00

Diabetic Emergencies

The EvidenceCare Diabetic Emergencies pathway provides treatment guidelines for the most common and immediately life-threatening diabetes complications: hyperglycemia, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar state (HHS), and hypoglycemia. The pathway also provides treatment recommendations for pediatric patients with hypoglycemia and diabetic ketoacidosis.

The recommendations are based on the latest research from American Diabetes Association, Diabetes Care, and Diabetologia.

CME Credits: 1.00

Gastro-esophageal Reflux Disease

Patients with Gastro-Esophageal Reflux Disease (GERD) may present with typical, atypical (extraesophageal) or refractory symptoms.

The EvidenceCare GERD pathway addresses these presentations of GERD providing diagnostic, treatment, and referral recommendations including management of GERD in pregnancy. We also help providers identify any Alarm Symptoms that would prompt referral to a GI specialist.

Recommendations are based on current research and recommendations from The American College of Gastroenterology and The American Gastroenterology Association.

CME Credits: 2.00

Low Risk Chest Pain

Chest pain is the second most common presentation in the emergency department with an estimated 5 million patients presenting annually. A large percentage of these patients are at a Low Risk for acute coronary syndrome and can be safely managed on an Outpatient basis.

The EvidenceCare Low Risk Chest Pain pathway helps providers risk stratified their patient who presents with chest pain that the provider does not have suspicion for Acute Coronary Syndrome (ACS). The strengths and limitations of 5 risk stratification tools (the HEART Score, HEART Pathway, HEARTS3, EDACS-ADP, and ADAPT-ADP) are reviewed. Each of these tools have been validated and have the ability to identify patients at Low Risk for Major Adverse Cardiac Event (MACE) within the next 30 days.

Armed with EvidenceCare, providers can take this information to the bedside to have a meaningful shared-decision making discussion with their patient.

CME Credits: 1.00

Neonatal Fever

The optimal diagnostic workup, empiric treatment, and appropriate disposition of the neonate (infants).

The EvidenceCare Neonatal Fever pathway consolidates the most recent research in this area, and present a protocolized approach. We cover initial assessment and risk stratification of patients in Low Risk and High Risk groups (based on Boston, Rochester, and Philadelphia criteria), decisions about appropriate diagnostic workup, and optimal treatment for your patient.

CME Credits: 2.00

Opioid Management

The abuse of prescription drugs is a serious societal and public health problem in the United States (Arizona Opioid Prescribing Guidelines, 2014). The epidemic of prescription opioid overdose deaths continues to climb. Since 1999, there have been more than 165,000 deaths from overdose related to prescription opioids (CDC, 2016).

The EvidenceCare Opioid Pathway is based off of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, the 2014 Arizona Opioid Prescribing Guidelines, the 2013 ICSI Institute For Clinical Systems Improvement Assessment and Management of Chronic Pain, and the 2014 ICSI Institute For Clinical Systems Improvement Acute Pain Assessment and Opioid Prescribing Protocol.

The pathway provides essential information for providers in the management, recommendations, and treatment of patient’s with acute pain, chronic pain, and withdrawal related to opioids.

CME Credits: 1.00

Pediatric Appendicitis

Acute appendicitis is the most common surgical emergency in children and diagnosis is often challenging.A classic presentation is often lacking in children, who may present with vague and nonspecific signs and symptoms that mimic common conditions, such as gastroenteritis.

Imaging strategies to aid in the diagnosis of appendicitis include Ultrasound, CT and MRI.Providers must consider if imaging is necessary, and if so, the strengths and limitations of each modality, including potential cancer risk from radiation exposure.

The EvidenceCare Pediatric Appendicitis Pathway helps providers risk stratify patients to improve decision making.The Alvarado score, Pediatric Appendicitis Score, Harbor-UCLA Clinical Practice Guideline and Clinical Gestalt are all considered in risk stratification and management of suspected appendicitis.

CME Credits: 4.00

Genevieve Santillanes, MD
P
ediatric Appendicitis 
Pediatric Advanced Life Support (PALS)

The EvidenceCare Pediatric Advanced Life Support (PALS) pathway offers providers a structured approach to managing pediatric arrhythmias (bradycardia, tachycardia), pediatric resuscitation and post arrest care. We summarize survival outcome data for in-hospital and out-of-hospital cardiac arrests (OHCA).

Recommendations are based off of the 2015 American Heart Association (AHA) guidelines.

CME Credits: 2.00

Pneumonia

The EvidenceCare Pneumonia pathway allows the provider to determine the optimal treatment protocol for a patient with suspected Pneumonia, or Ventilator-Associated Pneumonia (VAP). After performing a thorough assessment and work-up of the patient, the user is guided through risk stratification of the patient’s clinical severity using the CURB-65, the Pneumonia Severity Index (PSI), or clinical gestalt.

The source of the patient’s pneumonia (Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP) and Healthcare-Associated Pneumonia (HCAP)) and whether they have risks for Multi-Drug Resistant Organisms (MDROs) are used to determine the best antibiotic regimen.

Guidelines that are used in this pathway include the American Thoracic Society Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia, the NICE Guidelines for Pneumonia, and the IDSA/ATS Community-Acquired Pneumonia Guidelines.

CME Credits: 1.00

Pulmonary Embolism

The diagnostic workup and proper treatment approach to patients with pulmonary embolism can be challenging.

The EvidenceCare Pulmonary Embolism pathway includes a diagnostic algorithm using the Wells Score and PERC rule as well as workup of the pregnant patient. For patients positive for pulmonary embolism we help the provider risk stratify their patient including whether they have intermediate (submassive) or massive clot burden. From there we help the provider go through appropriate anticoagulation options, indications and contraindications to fibrinolytic therapy. Indications for catheter-directed fibrinolysis, ECMO, and rescue embolectomy are also discussed.

CME Credits: 6.00

Seizures

The EvidenceCare Seizure pathway provides treatment guidelines for management of seizures in the hospital setting and includes recommendations for new onset seizures, alcohol withdrawal seizures, and recurrent seizures in both adults and pediatric patients. Treatment recommendations address emergent initial treatment, urgent control therapy and treatment of refractory status epilepticus.

Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians and Neurocritical Care Society (NCS).

CME Credits: 3.00

Sepsis

Sepsis kills over 258,000 and is one of the mostly costly conditions in our healthcare system.

The EvidenceCare Sepsis pathway provides treatment recommendations based on whether the patient has Sepsis, Severe Sepsis, or is in Septic Shock. We help providers determine when to utilize qSOFA, SOFA, and ultrasound-guided fluid resuscitation.

These recommendations are based off of the 2015 updated Surviving Sepsis Campaign guidelines, the recently released Sepsis-3 guidelines, and data from the ProCESS, ARISE, and PROMISE trials.

CME Credits: 2.00

Stroke

Stroke is the leading cause of disability in the United States.

The EvidenceCare Stroke pathway consolidates information essential for providers evaluating patients with concern for transient ischemic attacks (TIAs) or cerebrovascular accidents (Strokes). Outlined are the recommendations for fibrinolytic therapy in acute ischemic stroke, including data from the 2015 AHA Advisory statement regarding changes to the inclusion and exclusion criteria for administration of tPA. The pathway highlights new endovascular interventional approaches in Acute Ischemic Stroke. Also included is data from the 2016 ATACH-2 study, providing recommendations for blood pressure control in hemorrhagic stroke.

Information is based off of the 2013 American Heart Association (AHA) Acute Ischemic Stroke Guidelines and the 2015 updated AHA recommendations for Endovascular intervention, the 2015 AHA Management of a Spontaneous Intracerebral Hemorrhage Guidelines, the 2012 AHA Guidelines for Management of the Aneurysmal Subarachnoid and the 2014 AHA Guidelines for the Prevention of Stroke in patients with Stroke and Transient Ischemic Attack.

CME Credits: 10.00

COMING SOON

ODG Worker's Comp

Guide Coming Soon

Congestive Heart Failure

Pathway Coming Soon